Torrent Pharma

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE685A01028
  • NSEID: TORNTPHARM
  • BSEID: 500420
INR
4,698.80
82.8 (1.79%)
BSENSE

Nov 20

BSE+NSE Vol: 2.05 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Mankind Pharma
Divi's Lab.
Laurus Labs
Aurobindo Pharma
Zydus Lifesci.
Torrent Pharma
Dr Reddy's Labs
Glenmark Pharma
Cipla
Lupin
Sun Pharma.Inds.
Why is Torrent Pharmaceuticals Ltd. ?
1
High Management Efficiency with a high ROCE of 22.96%
2
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 1.10 times
3
Strong Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 22.96%
4
Flat results in Sep 26
  • INTEREST(Latest six months) At Rs 605.00 cr has Grown at 115.30%
5
Stock is technically in a Mildly Bullish range
  • Multiple factors for the stock are Bullish like MACD, Bollinger Band and KST
6
With ROCE of 13.1, it has a Very Expensive valuation with a 6.4 Enterprise value to Capital Employed
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 26.39%, its profits have risen by 0.4%
7
High Institutional Holdings at 30.68%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
8
Company is among the highest 1% of companies rated by MarketsMojo across all 4,000 stocks
9
Consistent Returns over the last 3 years
  • Along with generating 26.39% returns in the last 1 year, the stock has outperformed BSE500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Torrent Pharma should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Torrent Pharma for you?

Low Risk, High Return

Absolute
Risk Adjusted
Volatility
Torrent Pharma
26.39%
1.16
22.76%
Sensex
-2.0%
-0.13
14.98%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
16.23%
EBIT Growth (5y)
15.70%
EBIT to Interest (avg)
8.32
Debt to EBITDA (avg)
1.60
Net Debt to Equity (avg)
0.61
Sales to Capital Employed (avg)
0.88
Tax Ratio
25.38%
Dividend Payout Ratio
59.45%
Pledged Shares
0
Institutional Holding
30.68%
ROCE (avg)
22.42%
ROE (avg)
20.35%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
82
Industry P/E
40
Price to Book Value
9.73
EV to EBIT
49.21
EV to EBITDA
32.88
EV to Capital Employed
6.44
EV to Sales
10.91
PEG Ratio
NA
Dividend Yield
0.72%
ROCE (Latest)
13.08%
ROE (Latest)
11.84%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

13What is working for the Company
NET SALES(Q)

Highest at Rs 4,979.00 cr

PBDIT(Q)

Highest at Rs 1,666.00 cr.

-8What is not working for the Company
INTEREST(Latest six months)

At Rs 605.00 cr has Grown at 115.30%

Loading Valuation Snapshot...
Here's what is working for Torrent Pharma
Net Sales - Quarterly
Highest at Rs 4,979.00 cr and Grown
each quarter in the last five quarters
MOJO Watch
Near term sales trend is very positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 1,666.00 cr. and Grown
each quarter in the last five quarters
MOJO Watch
Near term Operating Profit trend is quite positive

Operating Profit (Rs Cr)

Net Sales - Quarterly
At Rs 4,979.00 cr has Grown at 26.7% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 3,930.75 Cr
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Here's what is not working for Torrent Pharma
Interest - Latest six months
At Rs 605.00 cr has Grown at 115.30%
over previous Half yearly period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)